Myrbetriq[R] Patent Invalidated On Grounds Not Asserted By Any Party Violating Party Presentation Principle

In Astellas Pharma Inc. v. Sandoz Inc,, et al, following a five-day patent claims bench trial the court found asserted claims 5, 20, and 25 invalid under 35 U.S.C. § [...]